NFL Launches Medical Inquiry After Lawmakers Challenge Player Safety Protocols
Washington, Sunday, 22 November 2026.
Facing congressional scrutiny, the NFL and players’ union launched an independent review of medical protocols after quarterback Jalen Hurts developed life-threatening lung blood clots following an international flight.
Congressional Pressure Spurs Medical Review
U.S. Senator Lisa Blunt Rochester (D-Del.) has intensified pressure on the National Football League (NFL) to overhaul its medical protocols for managing deep vein thrombosis and blood clots, following the high-profile case of Philadelphia Eagles quarterback Jalen Hurts [1][2]. The Democratic senator, whose husband died from a pulmonary embolism, sent a formal inquiry to NFL Commissioner Roger Goodell on September 22, 2026, demanding clarity on league-wide safeguards for players [1]. Her legislative and advocacy work on blood clot awareness, including the introduction of federal legislation and public resource guides, underscores the bipartisan urgency of the issue [2].
Timeline of Events: From Injury to Review
Jalen Hurts’ ordeal began during an October 4, 2026, game against the Los Angeles Rams in London, where he suffered a lower-leg injury [1]. On October 8, he reported the injury to team medical staff, and an ultrasound on October 11 confirmed a superficial blood clot in his calf [1]. Post-flight testing revealed the clot had migrated, forcing Hurts onto the injured reserve list and ending his season [1]. By October 19, the Philadelphia Eagles and Hurts’ agent confirmed a bilateral pulmonary embolism diagnosis, with blood thinners prescribed [1]. The NFL’s response, delivered by Executive Vice President Jeff Miller on November 6, 2026, pledged a joint review with the NFL Players Association (NFLPA) using mutually agreed-upon independent medical experts [1].
NFL’s Response and Future Implications
In a November 6 letter to Senator Blunt Rochester, NFL Executive Vice President Jeff Miller outlined the league’s commitment to a collaborative review, emphasizing that findings and recommendations would be shared with both parties [1]. Miller’s response also signaled potential league-wide policy updates, stating that the NFL and NFLPA would evaluate ‘appropriate next steps’ based on the review’s conclusions [1]. The review’s scope extends beyond Hurts’ case, targeting systemic gaps in player safety protocols, particularly regarding blood clot management during travel and post-injury care [1][2].
Broader Context: A Personal and Public Health Crisis
Senator Blunt Rochester’s personal connection to the issue—her husband’s death from a pulmonary embolism—has amplified her advocacy, framing the NFL’s review as both a policy imperative and a public health necessity [2]. Pulmonary embolisms, which affect approximately 1 in 1,000 people annually and are the third-leading cause of heart-related death in the U.S., pose significant risks to athletes exposed to high-impact environments and prolonged travel [2][GPT]. The NFL’s decision to engage independent experts reflects a broader reckoning with occupational health standards in professional sports, where medical liability and workplace safety have become central to labor and regulatory debates [1][2].